UBU7:F:F-UBS (Irl) ETF Public Limited Company - MSCI World UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 81.728

Change

-0.75 (-0.90)%

Market Cap

USD 0.53B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.18 (-0.35%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.04 (-0.28%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.32%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+0.29 (+0.31%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.85 (-0.80%)

USD 45.80B
0ZC:F Zscaler Inc

-3.20 (-1.54%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.35%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing UBU7:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.94% 24% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.94% 24% F 41% F
Trailing 12 Months  
Capital Gain 3.32% 56% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.32% 54% F 52% F
Trailing 5 Years  
Capital Gain 72.16% 71% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.16% 71% C- 52% F
Average Annual (5 Year Horizon)  
Capital Gain 14.80% 86% B+ 75% C
Dividend Return 14.80% 84% B 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.16% 21% F 68% D+
Risk Adjusted Return 73.42% 74% C 80% B-
Market Capitalization 0.53B 62% D 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.